Molecular modelling in drug discovery.

被引:0
|
作者
Cornell, W [1 ]
机构
[1] Novartis Pharmaceut, Summit, NJ 07901 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
010-PRES
引用
收藏
页码:U27 / U27
页数:1
相关论文
共 50 条
  • [31] The changing role of peptides in drug discovery.
    Swistok, J
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U212 - U212
  • [32] Pattern recognition techniques in drug discovery.
    Richards, WG
    Robinson, DD
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U396 - U396
  • [33] Recent patents in automation in drug discovery.
    不详
    [J]. Nature Biotechnology, 2001, 19 (8) : 781 - 781
  • [34] Informative library design in drug discovery.
    Grootenhuis, PDJ
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U412 - U412
  • [35] Site-directed drug discovery.
    Wells, JA
    Erlanson, D
    DeLano, W
    Braisted, A
    Raphael, D
    Randal, M
    Stroud, R
    Gordon, E
    [J]. FASEB JOURNAL, 2001, 15 (04): : A28 - A28
  • [36] Visual environments for collaborative drug discovery.
    Ahlberg, C
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U522 - U522
  • [37] Discovery informatics: Integrating genomics and proteomics for drug discovery.
    Adams, MD
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U470 - U470
  • [38] Molecular characterization of human tumor xenografts for target-oriented drug discovery.
    Burger, AM
    Willmann, H
    Stappert, H
    Fiebig, HH
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 : 3875S - 3875S
  • [39] Reoptimization of MDL keys for use in drug discovery.
    Taylor, KT
    Durant, JL
    Leland, BA
    Henry, DR
    Nourse, JG
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U340 - U340
  • [40] Probabilistic approach to high throughput drug discovery.
    LaBule, P
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U412 - U412